PSMA PET/CT-Guided SBRT Plus Darolutamide in mHSPC

Clinical trial NCT07649421 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07649421
Sponsor: West China Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Start date: 2026-08-01
Primary completion: 2031-08-01
Enrollment: 254

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.